Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence

Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections. Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care Res Pract
Autors principals: Garg, Suneel Kumar, Singh, Omender, Juneja, Deven, Tyagi, Niraj, Khurana, Amandeep Singh, Qamra, Amit, Motlekar, Salman, Barkate, Hanmant
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518490/
https://ncbi.nlm.nih.gov/pubmed/28761764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3635609
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars